Leishen Energy Named as the No. 1 Bid Winner for Surface Control Integrated Devices with a Sinopec OilfieldBEIJING, June 16, 2026 (GLOBE NEWSWIRE) -- Leishen Energy Holding Co., Ltd. ("Leishen Energy" or the "Company") (
NASDAQ: LSE), a leading China-based provider of clean-energy equipment and integrated solutions for the oil and gas industry, today announced that ZJY Technologies Co., Ltd., its Chinese operating subsidiary, has once again been named the No. 1 Bid Winner in a major procurement tender by a Sinopec oilfield branch.
PPHC to Participate in Stifel’s Ninth Annual Boston Cross Sector 1x1 ConferenceWASHINGTON, May 29, 2026 (GLOBE NEWSWIRE) -- Public Policy Holding Company, Inc. ("PPHC" or "the Company") (Nasdaq: PPHC), a leading global provider of strategic communications services, today announced management’s participation during Stifel’s Ninth Annual Boston Cross Sector 1x1 Conference in Boston, MA being held from Tuesday, June 2 - Wednesday, June 3, 2026.
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual MeetingHONG KONG and FLORHAM PARK, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the American Society of Clinical Oncology (“ASCO”) Annual Meeting taking place from May 29 to June 2, 2026 in Chicago, USA.
Alpha FMC Appoints Charles Cummins as Senior Partner in North American Wealth Management TeamNEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Alpha Financial Markets Consulting (“Alpha FMC”), a leading global consultancy to the financial services industry, today announced the appointment of Charles Cummins as a Senior Partner within its North American Wealth Management consulting team.
Metals One to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21stCompany invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
Unaudited Preliminary Results for the Year Ended December 31, 2025LONDON and PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited preliminary results for the 12 months ended December 31, 2025 ("FY25").
Amaroq Ltd to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21stCompany invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, will today present two new developments at its Science Day 2026 event.
Galantas Gold to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 6th 2026Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
PPHC Expands MultiState Associates' Stakeholder Engagement CapabilitiesWASHINGTON, May 01, 2026 (GLOBE NEWSWIRE) -- Public Policy Holding Company, Inc. ("PPHC" or "the Company") (
NASDAQ: PPHC), a leading global strategic communications provider, today announced that MultiState, a PPHC subsidiary providing state-level government relations, has hired Lee Cowen and Nicholas Evans, specialists in federal, state, and local government relations, through the acquisition of the assets of their respective management companies Cowen Consulting, LLC and Putnam Strategies, LLC.
Concordant Launches Regulatory and Political Due Diligence Practice for Investors and Deal TeamsWASHINGTON, April 29, 2026 (GLOBE NEWSWIRE) -- Public Policy Holding Company, Inc. ("PPHC" or "the Company") (Nasdaq: PPHC), a leading global strategic communications provider, today announced that its Concordant Advisory subsidiary is expanding into regulatory and political due diligence, delivering board-ready diligence reports for investors, deal teams, and corporates evaluating high-stakes transactions and market entry.
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic AnemiaHONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for sovleplenib for the treatment of adult patients with warm antibody autoimmune hemolytic anemia (“wAIHA”) who have had an insufficient response to at least one previous glucocorticoid treatment has been accepted for review and granted priority review by the China National Medical Products Administration (“NMPA”). Sovleplenib is a novel, selective, oral inhibitor targeting spleen tyrosine kinase (“Syk”), being developed for the treatment of immune diseases and hematological malignancies.
PPHC to Report First Quarter 2026 Financial Results on May 12, 2026WASHINGTON, April 28, 2026 (GLOBE NEWSWIRE) -- Public Policy Holding Company, Inc. (“PPHC” or “the Company”) (Nasdaq: PPHC) (AIM: PPHC.L), a leading global strategic communications provider offering a comprehensive range of advisory services in the areas of Government Relations, Public Affairs and Corporate Communications, today announced that it will release its financial results for the three months ended March 31, 2026 (“Q1 Results”) on Tuesday, May 12, 2026, after market close.
Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 studyPotent and durable efficacy with iSCIB1+ of 77% progression free survival (PFS) at 20 months, in combination with ipilimumab and nivolumab, demonstrated in the Phase 2 SCOPE trial; more PFS and additional early overall survival (OS) data expected in H1 2027
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, April 28, 2026 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States.
Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platformPresentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug conjugate (ADC) Enhertu®
AI & Technology Virtual Investor Conference Agenda Announced for April 23rdCompany executives will discuss their business strategies, provide updates on recent developments, and answer questions live at VirtualInvestorConferences.com
Alpha FMC appoints new Senior Partner to lead global SimCorp partnershipNEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Alpha FMC (“Alpha”), a leading global consultancy to the financial services industry, today announces the appointment of Zoe Kohli as Senior Partner, Global Partner Executive in its Asset & Wealth Management practice.
The 2026 Insurance Outlook – Alpha FMC Research Shows Industry Moves from Tech Modernisation to Measurable PerformanceNEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- The global insurance industry is entering a new phase in which investments in technology, data and automation must translate into tangible improvements in underwriting performance, capital efficiency and customer outcomes, according to the 2026 Outlook for insurers from Alpha FMC, a leading global consultancy to the financial services industry.
OTC Markets Group Welcomes EnSilica PLC to OTCQXNEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced EnSilica PLC (AIM: ENSI; OTCQX: ENSIF), a leading fabless, micro-chipmaker with a growing portfolio of reusable IP, serving the Space & Comms, Industrial, Automotive and Healthcare markets, has qualified to trade on the OTCQX® Best Market.
